Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M611890-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,300.90 | |
M611890-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,000.90 |
Synonyms | Miricorilant|CORT118335|Miricorilant [INN]|Miricorilant [USAN]|CORT-118335|311Y5GV21M|Miricorilant [USAN:INN]|UNII-311Y5GV21M|1400902-13-7|CHEMBL2204043|WHO 10853|6-(trans-4-Phenylcyclohexyl)-5-((3-(trifluoromethyl)phenyl)methyl)-2,4(1H,3H)-pyrimidinedion |
---|---|
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of Glucocorticoid receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 6-(trans-4-phenylcyclohexyl)-5-{[3-(trifluoromethyl)phenyl]methyl}pyrimidine-2,4(1H,3H)-dione |
---|---|
INCHI | InChI=1S/C24H23F3N2O2/c25-24(26,27)19-8-4-5-15(13-19)14-20-21(28-23(31)29-22(20)30)18-11-9-17(10-12-18)16-6-2-1-3-7-16/h1-8,13,17-18H,9-12,14H2,(H2,28,29,30,31)/t17-,18- |
InChi Key | GVVUZBSCYAVFTI-IYARVYRRSA-N |
Canonical SMILES | O=c1[nH]c(=O)c(c([nH]1)[C@@H]1CC[C@H](CC1)c1ccccc1)Cc1cccc(c1)C(F)(F)F |
Isomeric SMILES | C1CC(CCC1C2=CC=CC=C2)C3=C(C(=O)NC(=O)N3)CC4=CC(=CC=C4)C(F)(F)F |
PubChem CID | 66550324 |
PubChem CID | 66550324 |
---|
Enter Lot Number to search for COA:
1. Gross C, Blasey CM, Roe RL, Belanoff JK. (2010) Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.. Obesity (Silver Spring), 18 (12): (2295-300). [PMID:20339369] |
2. Hunt HJ, Ray NC, Hynd G, Sutton J, Sajad M, O'Connor E, Ahmed S, Lockey P, Daly S, Buckley G et al.. (2012) Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat.. Bioorg Med Chem Lett, 22 (24): (7376-80). [PMID:23131342] |